Chinese General Practice ›› 2023, Vol. 26 ›› Issue (36): 4545-4551.DOI: 10.12114/j.issn.1007-9572.2023.0193
Special Issue: 肿瘤最新文章合辑; 肺癌最新文章合辑; 脑健康最新研究合辑
• Article • Previous Articles Next Articles
Received:
2023-01-20
Revised:
2023-05-06
Published:
2023-12-20
Online:
2023-06-07
Contact:
LIU Junyan, HAN Ying
通讯作者:
刘俊艳, 韩颖
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0193
组别 | 例数 | 年龄(岁) | 性别〔例(%)〕 | BMI (kg/m2) | 既往史〔例(%)〕 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
男 | 女 | 高血压 | CAHD | 2型糖尿病 | 脑梗死 | 心房颤动 | 高脂血症 | 主动吸烟史 | 饮酒史 | ||||
对照组 | 126 | 63.8±6.7 | 72(57.14) | 54(42.86) | 24.6±3.3 | 56(44.44) | 13(10.32) | 14(11.11) | 15(11.90) | 0 | 7(5.56) | 37(29.37) | 34(26.98) |
病例组 | 25 | 63.7±8.9 | 15(60.00) | 10(40.00) | 23.3±3.6 | 10(40.00) | 6(24.00) | 5(20.00) | 2(8.00) | 1(4.00) | 0 | 11(44.00) | 10(40.00) |
检验统计量值 | 0.083a | 0.070 | 1.724a | 0.168 | 3.051 | 1.344 | 0.344 | 3.631c | 2.601c | 2.061 | 1.712 | ||
P值 | 0.934 | 0.792 | 0.087 | 0.682 | 0.092 | 0.317 | 0.74 | 0.166 | 0.601 | 0.151 | 0.191 | ||
组别 | 用药史〔例(%)〕 | 术前化疗〔例(%)〕 | 白细胞计数(×109/L) | 红细胞计数(×1012/L) | 血红蛋白(g/L) | 血小板计数(×109/L) | |||||||
抗血小板聚集药 | 他汀类 | ||||||||||||
对照组 | 18(14.40) | 11(8.73) | 2(1.59) | 5.94±1.96 | 4.60±0.42 | 141.54±14.49 | 231.88±63.05 | ||||||
病例组 | 3(12.00) | 3(12.00) | 3(12.00) | 6.89±2.21 | 4.45±0.51 | 136.96±14.35 | 225.76±52.30 | ||||||
检验统计量值 | 0.103 | 0.249 | 5.024 | -2.164a | 1.482a | 1.446a | 0.455a | ||||||
P值 | 1.000 | 0.704 | 0.032 | 0.032 | 0.140 | 0.150 | 0.650 | ||||||
组别 | D-二聚体〔M(P25,P75),mg/L〕 | 纤维蛋白原(g/L) | eGFR 〔mL·min-1·(1.73 m2)-1〕 | SUA (μmol/L) | 血肌酐(μmol/L) | 总胆固醇(mmol/L) | 颅内外大动脉狭窄〔例(%)〕 | ||||||
对照组 | 0.10(0.06,0.18) | 2.95±0.62 | 97.42±9.54 | 326.06±80.47 | 59.90±12.22 | 4.98±1.02 | 9(11.39) | ||||||
病例组 | 0.14(0.07,0.21) | 3.32±0.84 | 98.64±12.21 | 286.86±79.40 | 59.14±14.28 | 5.20±1.18 | 4(33.33) | ||||||
检验统计量值 | -1.655b | -2.576a | -0.556a | 2.230a | 0.266a | -0.782a | 3.331 | ||||||
P值 | 0.098 | 0.011 | 0.579 | 0.027 | 0.790 | 0.436 | 0.065 |
Table 1 Comparison of baseline clinical characteristics between the case group and control group
组别 | 例数 | 年龄(岁) | 性别〔例(%)〕 | BMI (kg/m2) | 既往史〔例(%)〕 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
男 | 女 | 高血压 | CAHD | 2型糖尿病 | 脑梗死 | 心房颤动 | 高脂血症 | 主动吸烟史 | 饮酒史 | ||||
对照组 | 126 | 63.8±6.7 | 72(57.14) | 54(42.86) | 24.6±3.3 | 56(44.44) | 13(10.32) | 14(11.11) | 15(11.90) | 0 | 7(5.56) | 37(29.37) | 34(26.98) |
病例组 | 25 | 63.7±8.9 | 15(60.00) | 10(40.00) | 23.3±3.6 | 10(40.00) | 6(24.00) | 5(20.00) | 2(8.00) | 1(4.00) | 0 | 11(44.00) | 10(40.00) |
检验统计量值 | 0.083a | 0.070 | 1.724a | 0.168 | 3.051 | 1.344 | 0.344 | 3.631c | 2.601c | 2.061 | 1.712 | ||
P值 | 0.934 | 0.792 | 0.087 | 0.682 | 0.092 | 0.317 | 0.74 | 0.166 | 0.601 | 0.151 | 0.191 | ||
组别 | 用药史〔例(%)〕 | 术前化疗〔例(%)〕 | 白细胞计数(×109/L) | 红细胞计数(×1012/L) | 血红蛋白(g/L) | 血小板计数(×109/L) | |||||||
抗血小板聚集药 | 他汀类 | ||||||||||||
对照组 | 18(14.40) | 11(8.73) | 2(1.59) | 5.94±1.96 | 4.60±0.42 | 141.54±14.49 | 231.88±63.05 | ||||||
病例组 | 3(12.00) | 3(12.00) | 3(12.00) | 6.89±2.21 | 4.45±0.51 | 136.96±14.35 | 225.76±52.30 | ||||||
检验统计量值 | 0.103 | 0.249 | 5.024 | -2.164a | 1.482a | 1.446a | 0.455a | ||||||
P值 | 1.000 | 0.704 | 0.032 | 0.032 | 0.140 | 0.150 | 0.650 | ||||||
组别 | D-二聚体〔M(P25,P75),mg/L〕 | 纤维蛋白原(g/L) | eGFR 〔mL·min-1·(1.73 m2)-1〕 | SUA (μmol/L) | 血肌酐(μmol/L) | 总胆固醇(mmol/L) | 颅内外大动脉狭窄〔例(%)〕 | ||||||
对照组 | 0.10(0.06,0.18) | 2.95±0.62 | 97.42±9.54 | 326.06±80.47 | 59.90±12.22 | 4.98±1.02 | 9(11.39) | ||||||
病例组 | 0.14(0.07,0.21) | 3.32±0.84 | 98.64±12.21 | 286.86±79.40 | 59.14±14.28 | 5.20±1.18 | 4(33.33) | ||||||
检验统计量值 | -1.655b | -2.576a | -0.556a | 2.230a | 0.266a | -0.782a | 3.331 | ||||||
P值 | 0.098 | 0.011 | 0.579 | 0.027 | 0.790 | 0.436 | 0.065 |
组别 | 例数 | 手术方式〔例(%)〕 | 切除部位〔例(%)〕 | 手术持续时间(min) | 麻醉持续时间(min) | |||||
---|---|---|---|---|---|---|---|---|---|---|
开胸 | 胸腔镜 | LUL或LP | 其他 | |||||||
对照组 | 126 | 1(0.79) | 125(99.21) | 38(30.16) | 88(69.84) | 144.75±45.07 | 198.11±46.50 | |||
病例组 | 25 | 3(12.00) | 22(88.00) | 10(40.00) | 15(60.00) | 173.60±58.21 | 237.20±62.15 | |||
χ2(t)值 | 10.159 | 0.932 | -2.778a | -3.617a | ||||||
P值 | 0.001 | 0.334 | 0.006 | <0.001 | ||||||
组别 | 术中血压参数(mmHg) | 病理类型〔例(%)〕 | 疾病分期〔例(%)〕 | 脉管侵犯〔例(%)〕 | 脏层胸膜受侵〔例(%)〕 | |||||
最大SBP | 最小SBP | 平均SBP | SBP CV | 腺癌 | 鳞癌 | 早期 | 晚期 | |||
对照组 | 141±13 | 107±9 | 122±8 | 7.08±2.67 | 111(88.10) | 15(11.90) | 118(93.65) | 8(6.35) | 2(1.59) | 11(8.73) |
病例组 | 138±14 | 108±13 | 122±11 | 5.83±3.09 | 19(76.00) | 6(24.00) | 20(80.00) | 5(20.00) | 2(8.00) | 6(24.00) |
χ2(t)值 | 1.328a | -0.514a | -0.117a | 2.086a | 2.549 | 4.941 | 2.462 | 4.059 | ||
P值 | 0.186 | 0.608 | 0.907 | 0.039 | 0.110 | 0.026 | 0.128 | 0.039 |
Table 2 Surgical and pathology-related indicators
组别 | 例数 | 手术方式〔例(%)〕 | 切除部位〔例(%)〕 | 手术持续时间(min) | 麻醉持续时间(min) | |||||
---|---|---|---|---|---|---|---|---|---|---|
开胸 | 胸腔镜 | LUL或LP | 其他 | |||||||
对照组 | 126 | 1(0.79) | 125(99.21) | 38(30.16) | 88(69.84) | 144.75±45.07 | 198.11±46.50 | |||
病例组 | 25 | 3(12.00) | 22(88.00) | 10(40.00) | 15(60.00) | 173.60±58.21 | 237.20±62.15 | |||
χ2(t)值 | 10.159 | 0.932 | -2.778a | -3.617a | ||||||
P值 | 0.001 | 0.334 | 0.006 | <0.001 | ||||||
组别 | 术中血压参数(mmHg) | 病理类型〔例(%)〕 | 疾病分期〔例(%)〕 | 脉管侵犯〔例(%)〕 | 脏层胸膜受侵〔例(%)〕 | |||||
最大SBP | 最小SBP | 平均SBP | SBP CV | 腺癌 | 鳞癌 | 早期 | 晚期 | |||
对照组 | 141±13 | 107±9 | 122±8 | 7.08±2.67 | 111(88.10) | 15(11.90) | 118(93.65) | 8(6.35) | 2(1.59) | 11(8.73) |
病例组 | 138±14 | 108±13 | 122±11 | 5.83±3.09 | 19(76.00) | 6(24.00) | 20(80.00) | 5(20.00) | 2(8.00) | 6(24.00) |
χ2(t)值 | 1.328a | -0.514a | -0.117a | 2.086a | 2.549 | 4.941 | 2.462 | 4.059 | ||
P值 | 0.186 | 0.608 | 0.907 | 0.039 | 0.110 | 0.026 | 0.128 | 0.039 |
观察指标 | β | SE | Wald χ2值 | OR(95%CI) | P值 |
---|---|---|---|---|---|
术前化疗 | 2.135 | 0.942 | 5.138 | 8.455(1.335,53.541) | 0.023 |
高血压 | -0.182 | 0.446 | 0.167 | 0.833(0.348,1.997) | 0.683 |
2型糖尿病 | 0.693 | 0.575 | 1.454 | 2.000(0.648,6.170) | 0.228 |
颅内外大动脉狭窄 | 1.358 | 0.707 | 3.687 | 3.889(0.972,15.560) | 0.055 |
白细胞计数 | 0.201 | 0.097 | 4.311 | 1.223(1.011,1.479) | 0.038 |
纤维蛋白原 | 0.740 | 0.304 | 5.935 | 2.097(1.156,3.804) | 0.015 |
SUA | -0.007 | 0.003 | 4.718 | 0.993(0.987,0.999) | 0.030 |
手术方式 | |||||
开胸 | 2.836 | 1.178 | 5.799 | 17.045(1.695,171.395) | 0.016 |
手术持续时间 | 0.012 | 0.004 | 6.833 | 1.012(1.003,1.020) | 0.009 |
麻醉持续时间 | 0.015 | 0.005 | 10.227 | 1.015(1.006,1.024) | 0.001 |
脏层胸膜受侵 | 1.194 | 0.565 | 4.473 | 3.301(1.092,9.986) | 0.034 |
疾病分期 | |||||
晚期 | 1.305 | 0.619 | 4.441 | 3.688(1.096,12.412) | 0.035 |
Table 3 Univariate Logistic regression analysis of the influencing factors of POAIS in patients with NSCLC
观察指标 | β | SE | Wald χ2值 | OR(95%CI) | P值 |
---|---|---|---|---|---|
术前化疗 | 2.135 | 0.942 | 5.138 | 8.455(1.335,53.541) | 0.023 |
高血压 | -0.182 | 0.446 | 0.167 | 0.833(0.348,1.997) | 0.683 |
2型糖尿病 | 0.693 | 0.575 | 1.454 | 2.000(0.648,6.170) | 0.228 |
颅内外大动脉狭窄 | 1.358 | 0.707 | 3.687 | 3.889(0.972,15.560) | 0.055 |
白细胞计数 | 0.201 | 0.097 | 4.311 | 1.223(1.011,1.479) | 0.038 |
纤维蛋白原 | 0.740 | 0.304 | 5.935 | 2.097(1.156,3.804) | 0.015 |
SUA | -0.007 | 0.003 | 4.718 | 0.993(0.987,0.999) | 0.030 |
手术方式 | |||||
开胸 | 2.836 | 1.178 | 5.799 | 17.045(1.695,171.395) | 0.016 |
手术持续时间 | 0.012 | 0.004 | 6.833 | 1.012(1.003,1.020) | 0.009 |
麻醉持续时间 | 0.015 | 0.005 | 10.227 | 1.015(1.006,1.024) | 0.001 |
脏层胸膜受侵 | 1.194 | 0.565 | 4.473 | 3.301(1.092,9.986) | 0.034 |
疾病分期 | |||||
晚期 | 1.305 | 0.619 | 4.441 | 3.688(1.096,12.412) | 0.035 |
观察指标 | SUA | 高血压 | 2型糖尿病 | 颅内外大动脉狭窄 |
---|---|---|---|---|
SUA | 1 | — | — | — |
高血压 | 0.204a | 1 | — | — |
2型糖尿病 | -0.064 | 0.229a | 1 | — |
颅内外大动脉狭窄 | -0.022 | 0.162 | 0.326a | 1 |
Table 4 Correlation analysis of SUA with hypertension,type 2 diabetes mellitus,intracranial and extracranial large artery stenosis
观察指标 | SUA | 高血压 | 2型糖尿病 | 颅内外大动脉狭窄 |
---|---|---|---|---|
SUA | 1 | — | — | — |
高血压 | 0.204a | 1 | — | — |
2型糖尿病 | -0.064 | 0.229a | 1 | — |
颅内外大动脉狭窄 | -0.022 | 0.162 | 0.326a | 1 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] | |
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[35] |
|
[36] |
|
[37] |
|
[38] |
苑杰,路月英,郭鑫,等. 血清尿酸水平对急性缺血性脑卒中后抑郁的预测价值研究[J]. 中国全科医学,2018,21(16):1974-1979. DOI:10.3969/j.issn.1007-9572.2018.16.014.
|
[39] |
|
[40] |
|
[41] |
|
[42] |
|
[43] |
|
[44] |
|
[1] | MA Juan, MA Shengzong, YAN Ru, MA Xueping, JIA Shaobin. Predictive Effect of C-reactive Protein Albumin Ratio on Long-term Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction [J]. Chinese General Practice, 2025, 28(06): 705-712. |
[2] | WANG Rui, OUYANG Lina, WU Qian, NIU Yuanyuan, LI Guilan, ZHU Li. The Value of CT-FFR in Predicting Major Adverse Cardiovascular Events in Patients with Obstructive Coronary Artery Disease [J]. Chinese General Practice, 2025, 28(06): 713-719. |
[3] | LIU Zuting, XU Minghuan, YANG Xuezhi, MO Jiali, LIU Xingyu, DU Huijie, ZHANG Huiqin, YI Yingping, KUANG Jie. Correlation between the Systemic Inflammatory Response Index and Risk of Ischemic Stroke Recurrence [J]. Chinese General Practice, 2025, 28(05): 541-547. |
[4] | DU Huijie, LIU Xingyu, XU Minghuan, YANG Xuezhi, ZHANG Huiqin, MO Jiali, LU Yi, KUANG Jie. Advances in the Prognostic Prediction of Acute Ischemic Stroke: Using Machine Learning Predictive Models as an Example [J]. Chinese General Practice, 2025, 28(05): 554-560. |
[5] | ZHANG Pingshu, XUE Jing, XING Aijun, WANG Lianhui, MA Qian, FU Yongshan, YUAN Xiaodong. Study on Sleep Status and Prognostic Factors in Patients with Acute Posterior Circulation Ischemic Stroke [J]. Chinese General Practice, 2025, 28(05): 548-553. |
[6] | ZHU Lu, AI Jun, LIAO Shengwu, HUANG Shuting, GONG Nirong, KONG Yaozhong, LIU Dehui, DOU Xianrui, ZHANG Guangqing. Association of Prognostic Nutritional Index with Cardiovascular Mortality in Patients with Peritoneal Dialysis: a Multicenter Retrospective Cohort Study [J]. Chinese General Practice, 2025, 28(05): 568-574. |
[7] | ZHANG Jiaming, WANG Xinyu, WANG Daorong, SUN Xiaofang. Reference Equations for the 6-Minute Walk Test Distance in Outpatient Obese Patients Aged 17 to 45 Years [J]. Chinese General Practice, 2025, 28(03): 330-334. |
[8] | GAO Yan, YANG Shuxian, FAN Lei, CHANG Liang, GAO Li, ZHANG Hanxue, LI Hui, KANG Kai. Epidemic Characteristics and Influencing Factors of Bone and Joint Diseases among the Elderly Population [J]. Chinese General Practice, 2025, 28(03): 280-284. |
[9] | WU Xia, ZHANG Yiyun, YAO Chengzhi, ZHAO Xiangling, XIONG Wenjing, RANG Weiqing. Trend and Prediction of Changes in the Disease Burden of Diet-related Ischemic Heart Disease in China, 1990-2021 [J]. Chinese General Practice, 2025, 28(03): 305-312. |
[10] | YUAN Dan, WANG Ying, WANG Yingpeng, XU Li, XUE Jia, CHENG Jingjing, WANG Haipeng. Effect of the Remote Ischemic Postconditioning on the Prognosis of Patients with Acute Ischemic Stroke beyond Time Window: a Randomized Controlled Trial [J]. Chinese General Practice, 2025, 28(02): 169-174. |
[11] | LU Jing, SUN Guozhen, WANG Jie, GAO Min, YU Tianxi, SUN Shuyi, WANG Qin, WEN Gaoqin. Interpretable Analysis of Influencing Factors and the Current State of Social Frailty in Patients with Chronic Heart Failure [J]. Chinese General Practice, 2025, 28(02): 220-227. |
[12] | REN Xiaoqiao, WANG Pan, WU Hao, JI Yong, SHI Zhihong. Correlation of Serum Uric Acid to Serum Creatinine Ratio with the Recurrence of Cerebrovascular Events and Mortality in Patients with Acute Cerebrovascular Disease: a Prospective Cohort Study [J]. Chinese General Practice, 2025, 28(02): 175-182. |
[13] | LIU Qingping, KE Juzhong, SONG Jiahui, GAO Jiaojiao, LI Zhitao, WANG Xiaonan, QIU Hua, ZHOU Yi, RUAN Xiaonan, WU Kang. Trend of Onset Time of Diabetes Mellitus and Its Correlation with Chinese Visceral Adiposity Index: a Prospective Cohort Study [J]. Chinese General Practice, 2025, 28(02): 183-192. |
[14] | SHU Ting, LAN Zhipeng, WU Xia, LUO Yingjuan, YANG Liu. Study on the Infection and Related Factors of High-risk HPV in Cervical Cancer Screening Women: Based on 450 000 Participants in Chengdu [J]. Chinese General Practice, 2025, 28(02): 213-219. |
[15] | AN Ran, TANG Xin, QI Shige, WANG Zhihui, CUI Lu, ZHANG Han, GUO Haoyan. The Prevalence and Influencing Factors of Care Need among Community-dwelling Older People in Three Provinces of China [J]. Chinese General Practice, 2025, 28(01): 59-64. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||